Literature DB >> 21978530

Involvement of reactive oxygen species in 2-methoxyestradiol-induced apoptosis in human neuroblastoma cells.

Qi Zhang1, Yan Ma, Yue-Fang Cheng, Wen-Jie Li, Zhenzhong Zhang, Shao-Yu Chen.   

Abstract

Neuroblastoma is the most common extra-cranial solid tumor in children. Despite advances in the treatment of childhood cancer, outcomes for children with advanced-stage neuroblastoma remain poor. Here we reported that 2-methoxyestradiol (2-ME) inhibited the proliferation and induced apoptosis in human neuroblastoma SK-N-SH and SH-SY5Y cells. 2-ME treatment also resulted in the generation of ROS and the loss of mitochondrial membrane potential in SK-N-SH and SH-SY5Y, indicating that 2-ME-induced apoptosis is mediated by ROS. This is supported by the results that have shown that co-treatment with antioxidants, VC, L-GSH and MitoQ(10), decreased 2-ME-induced generation of ROS and the loss of the mitochondrial membrane potential, increased the Bcl-2/Bax ratio, decreased 2-ME-induced activation of caspase-9 and caspase-3 and the up-regulation of apoptosis-inducing factor (AIF), and prevented 2-ME-induced apoptosis in SK-N-SH and SH-SY5Y cells. These results suggested that oxidative stress plays an important role in 2-ME-induced apoptotic death of human neuroblastoma cells.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21978530      PMCID: PMC3224534          DOI: 10.1016/j.canlet.2011.09.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  54 in total

1.  Estrogen metabolomics: a physiologist's perspective.

Authors:  Virginia M Miller
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

Review 2.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

3.  Effects of the mass screening of neuroblastoma in Sapporo City.

Authors:  M Nishi; H Miyake; T Takeda; M Shimada; N Takasugi; Y Sato; J Hanai
Journal:  Cancer       Date:  1987-08-01       Impact factor: 6.860

4.  A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.

Authors:  Matthew H Kulke; Jennifer A Chan; Jeffrey A Meyerhardt; Andrew X Zhu; Thomas A Abrams; Lawrence S Blaszkowsky; Eileen Regan; Carolyn Sidor; Charles S Fuchs
Journal:  Cancer Chemother Pharmacol       Date:  2010-10-20       Impact factor: 3.333

Review 5.  Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?

Authors:  B T Zhu; A H Conney
Journal:  Cancer Res       Date:  1998-06-01       Impact factor: 12.701

6.  2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.

Authors:  Dharminder Chauhan; Laurence Catley; Teru Hideshima; Guilan Li; Richard Leblanc; Deepak Gupta; Martin Sattler; Paul Richardson; Robert L Schlossman; Klaus Podar; Edie Weller; Nikhil Munshi; Kenneth C Anderson
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

Review 7.  Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.

Authors:  Giovambattista Pani; Renata Colavitti; Barbara Bedogni; Salvatore Fusco; Daniela Ferraro; Silvia Borrello; Tommaso Galeotti
Journal:  Curr Med Chem       Date:  2004-05       Impact factor: 4.530

Review 8.  Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation.

Authors:  Ling-hua Meng; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2007-09       Impact factor: 6.150

Review 9.  Potential vascular actions of 2-methoxyestradiol.

Authors:  Raghvendra K Dubey; Edwin K Jackson
Journal:  Trends Endocrinol Metab       Date:  2009-09-04       Impact factor: 12.015

Review 10.  New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.

Authors:  Susan L Mooberry
Journal:  Curr Opin Oncol       Date:  2003-11       Impact factor: 3.645

View more
  14 in total

Review 1.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

2.  AG1031 induces apoptosis through suppressing SIRT1/p53 pathway in human neuroblastoma cells.

Authors:  Jingxuan Fu; Hui Zhang; Yuling Zhang; Tao Zhang
Journal:  Mol Cell Biochem       Date:  2018-10-22       Impact factor: 3.396

3.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

4.  DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anti-cancer effect of 2-methoxyestradiol.

Authors:  Magdalena Gorska; Alicja Kuban-Jankowska; Michal Zmijewski; Antonella Marino Gammazza; Francesco Cappello; Maciej Wnuk; Monika Gorzynik; Iwona Rzeszutek; Agnieszka Daca; Anna Lewinska; Michal Wozniak
Journal:  Oncotarget       Date:  2015-06-20

5.  Activation of AKR1C1/ERβ induces apoptosis by downregulation of c-FLIP in prostate cancer cells: A prospective therapeutic opportunity.

Authors:  Huiyoung Yun; Jianping Xie; Aria F Olumi; Rita Ghosh; Addanki P Kumar
Journal:  Oncotarget       Date:  2015-05-10

Review 6.  Cancer drug resistance: redox resetting renders a way.

Authors:  Yuan Liu; Qifu Li; Li Zhou; Na Xie; Edouard C Nice; Haiyuan Zhang; Canhua Huang; Yunlong Lei
Journal:  Oncotarget       Date:  2016-07-05

7.  An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study.

Authors:  Lisa Repsold; Etheresia Pretorius; Annie Margaretha Joubert
Journal:  Cancer Cell Int       Date:  2014-06-07       Impact factor: 5.722

8.  ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription.

Authors:  Kai Li; Bo Gao; Jun Li; Haining Chen; Yanyan Li; Yuyan Wei; Di Gong; Junping Gao; Jie Zhang; Weiwei Tan; Tianfu Wen; Le Zhang; Lugang Huang; Rong Xiang; Ping Lin; Yuquan Wei
Journal:  Oncotarget       Date:  2015-11-10

9.  Exposure of Breast and Lung Cancer Cells to a Novel Estrone Analog Prior to Radiation Enhances Bcl-2-Mediated Cell Death.

Authors:  Elsie M Nolte; Anna M Joubert; Roy Lakier; Ado van Rensburg; Anne E Mercier
Journal:  Int J Mol Sci       Date:  2018-09-23       Impact factor: 5.923

Review 10.  ROS in cancer therapy: the bright side of the moon.

Authors:  Bruno Perillo; Marzia Di Donato; Antonio Pezone; Erika Di Zazzo; Pia Giovannelli; Giovanni Galasso; Gabriella Castoria; Antimo Migliaccio
Journal:  Exp Mol Med       Date:  2020-02-14       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.